Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Seres Therapeutics Inc MCRB

Healthcare Biotechnology
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. The Company is engaged in developing SER-155, which has demonstrated a significant reduction in bloodstream infections and related complications (as compared to placebo) in a clinical study in patients undergoing allogeneic... see more

Bullboard (NDAQ:MCRB)

View:
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Nov 22, 2024 4:00pm

Seres Therapeutics to Participate in Piper Sandler Healthcar

News; $MCRB Seres Therapeutics to Participate in Piper Sandler Healthcare ConferenceCAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live ...more  
22
Comment by Napcooon Mar 28, 2024 11:31pm

RE:Now it's time to accumulate @78 cents

Q4 earnings says as a result, we have confidence that we will ultimately achieve our goal of VOWST becoming a foundational therapy for our CDI, potentially reaching or surpassing the highest ...more  
95
Post by Napcooon Mar 28, 2024 11:26pm

Now it's time to accumulate @78 cents

$225 mln due if target milestone reached for the $575 mln deal, $175 mln upfront, $125 mln FDA approved, latest updates to reach sales target in 2024, which 2024 financial year? https://www ...more  
142
User Avatar Image
(0)
•••
  • IvanIvanX
Post by IvanIvanon Apr 27, 2023 3:34am

Price

In December 2020, when SER-109 passed phase 3, the price rose to $38. Expect it to be at that price again in a month. Analysts will increase the target price after FDA approval.
121
Post by hoffbagon Jan 15, 2023 2:06pm

Maybe a chance to accumulate

Below 5 again. Maybe right cap on approval is between 800 - 900 million? 
270
Post by hoffbagon Oct 31, 2022 5:10pm

Popping now!

Target valuation getting closer. 
108
Post by hoffbagon Sep 08, 2022 3:13pm

Patience cont….

Now over 6. 
97
Post by hoffbagon Aug 19, 2022 7:17pm

Patience and intestinal fortitude

Now over 5. 
123
Post by hoffbagon Jun 08, 2022 2:20pm

SER 109

The time has come.  BLA approval has a higher probability.  Potential multi-bagger. Last traded this on the run from 4 to 20 in 2020.  Lets have a repeat please.
119